Abstract
Myosmine, a minor tobacco alkaloid widely occurring in food products of plant and animal origin, inhibits the conversion of testosterone to estradiol by human aromatase (IC50: 33±2 μM) sevenfold more potent than nicotine (IC50: 223±10 μM) and may have implications for sexual hormone homoeostasis.
Keywords: CYP19, cytochrome P450, human aromatase, myosmine, nicotine
Drug Metabolism Letters
Title: Inhibition of Human Aromatase by Myosmine
Volume: 3 Issue: 2
Author(s): Irene L. Doering and Elmar Richter
Affiliation:
Keywords: CYP19, cytochrome P450, human aromatase, myosmine, nicotine
Abstract: Myosmine, a minor tobacco alkaloid widely occurring in food products of plant and animal origin, inhibits the conversion of testosterone to estradiol by human aromatase (IC50: 33±2 μM) sevenfold more potent than nicotine (IC50: 223±10 μM) and may have implications for sexual hormone homoeostasis.
Export Options
About this article
Cite this article as:
Doering L. Irene and Richter Elmar, Inhibition of Human Aromatase by Myosmine, Drug Metabolism Letters 2009; 3 (2) . https://dx.doi.org/10.2174/187231209788654045
DOI https://dx.doi.org/10.2174/187231209788654045 |
Print ISSN 1872-3128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-0758 |
Related Articles
-
Membrane Estrogen Receptors Acting in the Central Nervous System
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Synthesis of Medicinally Privileged Heterocycles through Dielectric Heating
Current Medicinal Chemistry Regulators of Chemokine Receptor Activity as Promising Anticancer Therapeutics
Current Cancer Drug Targets Integrative Analysis of miRNA-mediated Competing Endogenous RNA Network Reveals the lncRNAs-mRNAs Interaction in Glioblastoma Stem Cell Differentiation
Current Bioinformatics New Ways to Improve Breast Cancer Therapy Targeting Specific Molecular Pathways
Current Cancer Therapy Reviews Compounds From Celastraceae Targeting Cancer Pathways and Their Potential Application in Head and Neck Squamous Cell Carcinoma: A Review
Current Genomics Editorial [ Natural Products and Colon Drug Delivery ]
Current Drug Delivery Berberine as a Promising Safe Anti-Cancer Agent- Is there a Role for Mitochondria?
Current Drug Targets Potential Uses of MicroRNA in Lung Cancer Diagnosis, Prognosis, and Therapy
Current Cancer Drug Targets From Nanotechnology to Nanomedicine: Applications to Cancer Research
Current Molecular Medicine Targeting the JAK/STAT Signaling Pathway for Breast Cancer
Current Medicinal Chemistry The Applications of Biomarkers in Early Clinical Drug Development to Improve Decision-Making Processes
Current Clinical Pharmacology Doxorubicin-Loaded Nanoparticles: New Advances in Breast Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Study of Antioxidant, Antiproliferative and DNA Damage Protecting Activities of <i>Cinnamomum</i> cassia Extracts Obtained by Sequential Extraction
Recent Patents on Food, Nutrition & Agriculture Epidermal Growth Factor Receptor Inhibitors: A New Prospective in the Treatment of Lung Cancer
Current Medicinal Chemistry - Anti-Cancer Agents DoE Based Optimization and Development of Spray-Dried Chitosan-Coated Alginate Microparticles Loaded with Cisplatin for the Treatment of Cervical Cancer
Current Molecular Pharmacology Signal Transduction of Radiation and/or Hyperthermic Cancer Therapies
Current Signal Transduction Therapy Quinone-Based Drugs: An Important Class of Molecules in Medicinal Chemistry
Medicinal Chemistry Potential Advantages of Using Synchrotron X-ray Based Techniques in Pediatric Research
Current Medicinal Chemistry Improved Candidate Biomarker Detection Based on Mass Spectrometry Data Using the Hilbert-Huang Transform
Protein & Peptide Letters